MediWound (MDWD) Other Accumulated Expenses (2013 - 2025)
MediWound's (MDWD) quarterly Other Accumulated Expenses came in at $4.5 million in Q4 2025, up 27.42% year-on-year from $3.6 million in Q4 2024, and up 22.2% quarter-over-quarter from $3.7 million in Q3 2025.
MediWound (MDWD) Other Accumulated Expenses (2013 - 2025) Analysis & Trends
MediWound's Other Accumulated Expenses history runs 13 years deep, the most recent figure standing at $4.5 million for Q4 2025.
- On a quarterly basis, Other Accumulated Expenses rose 27.42% year-over-year to $4.5 million in Q4 2025; TTM through Dec 2025 was $4.5 million, a 27.42% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 27.42% from the prior year.
- Other Accumulated Expenses climbed to $4.5 million in Q4 2025 per MDWD's latest filing, from $3.7 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $5.2 million in Q1 2021 and bottomed at $2.7 million in Q3 2024.
- The 5-year median for Other Accumulated Expenses is $3.5 million (2024), against an average of $3.6 million.
- Across the five-year window, Other Accumulated Expenses sank 40.93% in 2022 and surged 39.19% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $3.6 million in 2021, then grew by 14.89% to $4.2 million in 2022, then slipped by 6.44% to $3.9 million in 2023, then slipped by 8.61% to $3.6 million in 2024, then increased by 27.42% to $4.5 million in 2025.
- Per Business Quant, the three latest MDWD Other Accumulated Expenses figures stand at $4.5 million (Q4 2025), $3.7 million (Q3 2025), and $3.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | MediWound | 166.67 Mn | 161.87 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.53 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Sep 30, 2023 | 3.07 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 3.06 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 4.38 Mn |
| Jun 30, 2021 | 3.92 Mn |
| Mar 31, 2021 | 5.17 Mn |